Chemed (CHE) Operating Expenses (2009 - 2026)

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Chemed was $2.25 billion, up 4.8% year-over-year; for FY2025, it came in at $2.19 billion, up 6.1% from FY2024.

• Annual Operating Expenses has increased for three consecutive years, with a five-year compound annual growth rate of 5.3% (FY2020 to FY2025).
• In prior years, Chemed's Operating Expenses was $2.06 billion in FY2024 (+7.3%), $1.92 billion in FY2023 (+7.4%), $1.79 billion in FY2022 (-0.3%) and $1.8 billion in FY2021 (+6.3%).
• The Q2 2026 figure stands as the highest quarterly Operating Expenses in data going back to Q2 2009.
• On a year-over-year basis, Operating Expenses has increased in each of the last 15 quarters, with growth averaging 6.6% over the last eight quarters.
• The strongest year-over-year quarter for Operating Expenses in the past five years was Q4 2021, with growth of 13.6%; the weakest was Q2 2022, with a decline of 4.6%.
• According to Business Quant data, Operating Expenses for the three prior quarters was $572.94 million (Q1 2026), $538.68 million (Q4 2025) and $550.15 million (Q3 2025).